Dr. David Ellis Disbrow, MD

Dr. Disbrow practices at Sante' Foundation Medical Group in Fresno, California.

Dr. Disbrow's NPI, 1730406901, was assigned on April 28, 2010. Dr. Disbrow graduated from Albany Medical College in 2010. Dr. Disbrow holds California license A148973.

Dr. Disbrow's primary practice is Sante' Foundation Medical Group, at 6121 N Thesta St Suite 202 Suite 202, Fresno, CA 93710-5294. The practice phone is (559) 438-7390.

Dr. Disbrow's primary practice is Sante' Foundation Medical Group in Fresno, California. Dr. Disbrow is also affiliated with Community Regional Medical Center. The medical group on file is Santé Foundation Medical Group. Dmand AI also links Dr. Disbrow to 2 more hospitals, 3 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Disbrow practices, 5 sites in all. Vendor and product names are available with a free account.

Colon and rectal surgery is Dr. Disbrow's primary specialty in the NPI Registry, under taxonomy code 208C00000X. Dr. Disbrow is board certified in colon & rectal surgery by the American Board of Colon and Rectal Surgery. Dmand AI has Dr. Disbrow's licenses on file in 3 states: California, Michigan and South Carolina.

Dmand AI lists colonoscopy, colon removal and hemorrhoids among the conditions Dr. Disbrow treats.

CMS data shows 394 Medicare services from Dr. Disbrow across 10 procedure codes in 2024, for 246 Medicare patients. Medicare paid $46,835 for them.

CMS counts 246 Medicare patients who saw Dr. Disbrow in 2024. The largest group is 65 to 74, with 126 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 26% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Disbrow's median patient age at 59, with 51% women.

In 2024, Dr. Disbrow wrote 302 Medicare Part D claims for 154 patients. 95% of them were for generic drugs. CMS names the drug for 248 of them, across 5 drugs with 11 or more claims each, at $3,582 in total drug cost. In 2023, CMS named 186 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Disbrow for performance year 2024, reported as part of a group. Dr. Disbrow accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 89 procedures of colonoscopy by Dr. Disbrow, more than 77% of the clinicians it reports for that procedure.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Disbrow, published from 2012 to 2018. Dr. Disbrow's most frequent co-authors are Robert K. Cleary, MD, David Lawrence Cull, MD and Beth-Ann Shanker, MD.

CMS Open Payments shows 79 general payments to Dr. Disbrow from 7 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 37% of the total. Intuitive Surgical, Inc. paid the most, $14,454.

Dmand AI lists 5 awards for Dr. Disbrow, most recently McAlhany Academic Resident of the Year Award in 2014.

Dr. Disbrow graduated from Albany Medical College in 2010. Dr. Disbrow is a member of ACS.

Dr. Disbrow is in network with 11 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.